nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activation of Cyclopropavir Involves Unique Phosphorylation by Guanylate Kinase
|
Gentry, Brian G. |
|
2009 |
82 |
2 |
p. A69- 1 p. |
artikel |
2 |
Activity of Certain 5-Substituted-4′-Thio Pyrimindine Nucleosides against Orthopoxvirus Infections
|
Kern, Earl |
|
2009 |
82 |
2 |
p. A72- 1 p. |
artikel |
3 |
Administration of a HepDirect™ Prodrug of 2′-C-methylcytidine to Hepatitis C Virus Infected Chimpanzees
|
Carroll, Steven |
|
2009 |
82 |
2 |
p. A22- 1 p. |
artikel |
4 |
A Heterocyclic Molecule with Significant Activity Against Dengue Virus
|
Nair, Vasu |
|
2009 |
82 |
2 |
p. A62- 1 p. |
artikel |
5 |
A High-content Screening Approach to Identify Compounds that Interfere with the Formation of the Hepatitis C Virus Replication Complex
|
Berke, J.M. |
|
2009 |
82 |
2 |
p. A27-A28 nvt p. |
artikel |
6 |
Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: Current state of the art
|
Hostetler, Karl Y. |
|
2009 |
82 |
2 |
p. A84-A98 nvt p. |
artikel |
7 |
A Macromolecular Basis for Microbicides Dual Protecting Against HIV and Cytomegalovirus Infection
|
Serbin, A. |
|
2009 |
82 |
2 |
p. A66- 1 p. |
artikel |
8 |
A Mass Spectrometry-based Method to Detect Antiviral Drug Resistance in Human Cytomegalovirus
|
Posthuma, Clara |
|
2009 |
82 |
2 |
p. A51- 1 p. |
artikel |
9 |
A Microbicide Perspective: Past, Present, and Future
|
Hillier, Sharon |
|
2009 |
82 |
2 |
p. A73- 1 p. |
artikel |
10 |
A New Series of Tricyclic Nucleosides as Potent Inhibitors of Hepatitis C Virus RNA Replication: Design, Synthesis and Structure–Activity Relationships
|
Keicher, Jesse |
|
2009 |
82 |
2 |
p. A29- 1 p. |
artikel |
11 |
Animal models for the study of influenza pathogenesis and therapy
|
Barnard, Dale L. |
|
2009 |
82 |
2 |
p. A110-A122 nvt p. |
artikel |
12 |
A Novel Small-molecule CCR5 Agonist, ESN-196, with Potent R5 HIV-1 Activity
|
Ferain, Thierry |
|
2009 |
82 |
2 |
p. A23-A24 nvt p. |
artikel |
13 |
Antiadenoviral Activity of 6-Azanucleoside Analogues
|
Nosach, Lidiya |
|
2009 |
82 |
2 |
p. A41- 1 p. |
artikel |
14 |
Anti-cytomegalovirus Activity of Membranotropic Polyacidic Agents Effects In Vitro
|
Pavlova, M. |
|
2009 |
82 |
2 |
p. A50-A51 nvt p. |
artikel |
15 |
Antiflogistics as Viral Inhibitors
|
Danilenko, Georgy |
|
2009 |
82 |
2 |
p. A54-A55 nvt p. |
artikel |
16 |
Anti-HIV-1 Activity of A3G is Enhanced by HSP70
|
Sugiyama, Ryuichi |
|
2009 |
82 |
2 |
p. A26- 1 p. |
artikel |
17 |
Anti-H5N1 Influenza Virus Activity of Carbocyclic Cytosine Nucleosides
|
Rao, J.R. |
|
2009 |
82 |
2 |
p. A62-A63 nvt p. |
artikel |
18 |
Anti-influenza Efficacy of Combination Apply of Proteolytic Inhibitor E-aminocaproic Acid with Neuraminidase Inhibitor Tamiflu
|
Lozitsky, V. |
|
2009 |
82 |
2 |
p. A34- 1 p. |
artikel |
19 |
Anti-Picornavirus Activity and Other Antiviral Activity of Sulfated Exopolysaccharide from the Marine Microalga Gyrodinium impudicum Strain KG03
|
Lee, Chong-Kyo |
|
2009 |
82 |
2 |
p. A40- 1 p. |
artikel |
20 |
Antiproliferative Effects of Octadecyloxyethyl-Phosphonomethoxyethylguanine (ODE-PMEG) on the Growth of Human Papilloma Virus Positive Cervical Carcinoma (ME-180) Cells In Vitro and Solid Tumors in Athymic Nude Mice
|
Trahan, Julissa |
|
2009 |
82 |
2 |
p. A42- 1 p. |
artikel |
21 |
Antiviral Activities of Nucleoside Analogs Against HSV-1 Replication in 143B Cells Expressing the Viral TK Genes with Different Initiation Codon Sites
|
Lee, Chong-Kyo |
|
2009 |
82 |
2 |
p. A48- 1 p. |
artikel |
22 |
Antiviral Activity of Carbohydrate Binding Agents (CBAS) and the Role of DC-SIGN in Dengue Virus and HIV Infection
|
Alen, Marijke |
|
2009 |
82 |
2 |
p. A22- 1 p. |
artikel |
23 |
Antiviral Activity of Geneticin Against Dengue Virus
|
Zhang, Xianchao |
|
2009 |
82 |
2 |
p. A42- 1 p. |
artikel |
24 |
Antiviral Activity of Monoterpene Components of Essential Oils Against Herpes Simplex Virus
|
Astani, Akram |
|
2009 |
82 |
2 |
p. A46- 1 p. |
artikel |
25 |
Antiviral Activity of New Derivatives of Cage Compounds
|
Klimochkin, Yuri |
|
2009 |
82 |
2 |
p. A60- 1 p. |
artikel |
26 |
Antiviral Activity of Octadecyloxypropyl Esters of 3-Hydroxy-2-(Phosphonomethoxy)Propyl Nucleosides Against Adenovirus In Vitro
|
Roth, J.P. |
|
2009 |
82 |
2 |
p. A41-A42 nvt p. |
artikel |
27 |
Antiviral Activity of Tetrahydro-2(1H)-Pyrimidinones and Related Compounds: Classification SAR Study
|
Kuz’min, V. |
|
2009 |
82 |
2 |
p. A61- 1 p. |
artikel |
28 |
Antiviral Activity of Unithiolum Against the Human Immunodeficiency Virus and Herpes Simplex Virus
|
Fedchuk, Alla |
|
2009 |
82 |
2 |
p. A23- 1 p. |
artikel |
29 |
Antiviral Effect of a Novel Inhibitor of Influenza Virus Hemagglutinin on Influenza A (H5N1) Virus
|
Rak, Svetlana |
|
2009 |
82 |
2 |
p. A35-A36 nvt p. |
artikel |
30 |
Arenaviral Inhibitory Activity of MY-24, a Novel Aristeromycin Derivative
|
Gowen, Brain |
|
2009 |
82 |
2 |
p. A39- 1 p. |
artikel |
31 |
A Role for Nitazoxanide in Combination with STAT-C Agents for Inhibition of HCV Replication and the Potential for the Prevention of Viral Resistance
|
Korba, Brent |
|
2009 |
82 |
2 |
p. A20- 1 p. |
artikel |
32 |
A Small Llama Antibody Fragment Efficiently Inhibits the HIV Rev Multimerization In Vitro
|
Vercruysse, Thomas |
|
2009 |
82 |
2 |
p. A27- 1 p. |
artikel |
33 |
Assay Development for Antiviral Drug Efficacy Evaluation Against Dengue Virus
|
Li, Qianjun |
|
2009 |
82 |
2 |
p. A40-A41 nvt p. |
artikel |
34 |
A Strong Dominant Negative Mutation in the HIV-1 Gag Protein Defines a New Drug Target
|
Swanstrom, Ronald |
|
2009 |
82 |
2 |
p. A43- 1 p. |
artikel |
35 |
A Study of the Safety and Pharmacokinetics of Multiple Ascending Doses of FV-100 in Healthy Subjects
|
Matson, Mark |
|
2009 |
82 |
2 |
p. A49- 1 p. |
artikel |
36 |
A Study of the Safety and Pharmacokinetics of Single and Multiple Doses of FV-100 in Subjects 65 Years and Over
|
Matson, Mark |
|
2009 |
82 |
2 |
p. A49- 1 p. |
artikel |
37 |
A Tetrazolo-pyrimidine Induces Intracellular Redistribution of Hepatitis B Surface Antigen, Resulting in Reduced Secretion
|
Goddard, Cally |
|
2009 |
82 |
2 |
p. A21- 1 p. |
artikel |
38 |
Beautiful Biology But Bad Chemistry: Recognizing Chemistry Problems Earlier Rather Than Later
|
Lipinski, Christopher |
|
2009 |
82 |
2 |
p. A19- 1 p. |
artikel |
39 |
Biophysical Mechanisms in Microbicide Pharmacokinetics
|
Katz, David |
|
2009 |
82 |
2 |
p. A74- 1 p. |
artikel |
40 |
Bioreversible Protection of Nucleosidediphosphates—Synthesis and Properties
|
Schulz, Tilmann |
|
2009 |
82 |
2 |
p. A63- 1 p. |
artikel |
41 |
CADA, a Potential Anti-HIV Microbicide that Specifically Targets the Cellular CD4 Receptor
|
Vermeire, Kurt |
|
2009 |
82 |
2 |
p. A66- 1 p. |
artikel |
42 |
Characterization of Cowpox Virus (CPV) Mutants Arising under Pressure with Different Acyclic Nucleoside Phosphonates
|
Andrei, Graciela |
|
2009 |
82 |
2 |
p. A53- 1 p. |
artikel |
43 |
Characterization of the Mechanism of Action of PG-301029: A Novel Late Stage Inhibitor of HCV Replicon Replication
|
Parsley, Todd |
|
2009 |
82 |
2 |
p. A31- 1 p. |
artikel |
44 |
Cinnamon Fraction Neutralizes Avian Influenza H5N1 Both In Vitro and In Vivo
|
Ovadia, Michael |
|
2009 |
82 |
2 |
p. A35- 1 p. |
artikel |
45 |
Clinical Failures of Select Polyanionic Microbicide Candidates may be Predicted by In Vitro Enhancement of HIV-1 Infection
|
Pirrone, Vanessa |
|
2009 |
82 |
2 |
p. A65-A66 nvt p. |
artikel |
46 |
Combination of Neuraminidase Inhibitors with T-705 for Treating Influenza Virus Infections in Cell Culture and in Mice
|
Smee, Donald |
|
2009 |
82 |
2 |
p. A37- 1 p. |
artikel |
47 |
Combinations of 5-Iodo-4′-thio-2′-deoxyuridine and ST-246 or CMX001 Synergistically Inhibit Orthopoxvirus Replication In Vitro
|
Keith, Kathy |
|
2009 |
82 |
2 |
p. A33-A34 nvt p. |
artikel |
48 |
Comparative Efficacy of Treatment with CMX001 Versus Acyclovir in BALB/c Mice Infected with Herpes Simplex Virus
|
Quenelle, Debra |
|
2009 |
82 |
2 |
p. A51-A52 nvt p. |
artikel |
49 |
Comparative Study of the Efficacy of Low- and High-Molecular Inhibitors of Influenza Virus Hemagglutinin
|
Rak, S. |
|
2009 |
82 |
2 |
p. A35- 1 p. |
artikel |
50 |
Comparative Study of the Genetic Barrier and Pathways Towards Resistance of Selective Inhibitors of HCV Replication
|
Vliegen, Inge |
|
2009 |
82 |
2 |
p. A21- 1 p. |
artikel |
51 |
Comparison of Various Combination Therapies for the Treatment of Yellow Fever Virus
|
Julander, Justin |
|
2009 |
82 |
2 |
p. A29- 1 p. |
artikel |
52 |
Compounds Designed to Bind Conserved Regions of Human Papillomavirus (HPV) DNA show Broad-spectrum Activity Against High-risk Genotypes
|
Bashkin, James |
|
2009 |
82 |
2 |
p. A54- 1 p. |
artikel |
53 |
Compounds that Target Host Cell Enzymes Prevent Varicella-zoster Virus Replication In Vitro, Ex Vivo, and in SCID-hu Mice
|
Rowe, J. |
|
2009 |
82 |
2 |
p. A52- 1 p. |
artikel |
54 |
Computer-aided Drug Design of Novel Anti-coxsackievirus B3 Nancy Agents by Means of Hit QSAR
|
Muratov, E. |
|
2009 |
82 |
2 |
p. A61- 1 p. |
artikel |
55 |
Conserved Retinoblastoma Protein-binding Motifs in Human Cytomegalovirus UL97 Minimally Impact Viral Replication But can Affect Susceptibility to Maribavir
|
Hartline, Caroll |
|
2009 |
82 |
2 |
p. A48- 1 p. |
artikel |
56 |
CXCR4 Antagonists: A New Generation of Configurationally Restricted Bis-azamacrocyclic Compounds
|
Khan, Abid |
|
2009 |
82 |
2 |
p. A59-A60 nvt p. |
artikel |
57 |
CXCR4 Chemokine Receptor Antagonists from Ultra-rigid Metal Complexes Profoundly Inhibit HIV-1 Replication, and also AMD3100-resistant Strains
|
Archibald, Stephen J. |
|
2009 |
82 |
2 |
p. A45- 1 p. |
artikel |
58 |
CycloSaligenyl-di-d4TMP: Highly Loaded CycloSal-pronucleotides that Release Two Equivalents of Nucleotides and Leaving One Masking Unit
|
Meier, Chris |
|
2009 |
82 |
2 |
p. A61- 1 p. |
artikel |
59 |
2′-Deoxy-nucleoside Analogs can be Potent Dual Inhibitors of HCV and HIV Replication with Selectivity against Human Polymerases
|
Klumpp, Klaus |
|
2009 |
82 |
2 |
p. A19- 1 p. |
artikel |
60 |
Derivatives of Tunicamycin as Effective Inhibitors of Classical Swine Fever Virus
|
Krol, Ewelina |
|
2009 |
82 |
2 |
p. A40- 1 p. |
artikel |
61 |
Design, Molecular Modelling Studies of Specific Targeted Candidate Inhibitors of HCV NS5B RNA Polymerase
|
Selvam, P. |
|
2009 |
82 |
2 |
p. A31-A32 nvt p. |
artikel |
62 |
Design of Artificial Polyepitope DNA Vaccine Constructs for Eliciting of HIV-Specific CD8+ CTL Responses
|
Oreshkova, Svetlana |
|
2009 |
82 |
2 |
p. A25- 1 p. |
artikel |
63 |
Design of Intravaginal Ring for Simultaneous Delivery of Antiretroviral Drugs
|
Johnson, Todd |
|
2009 |
82 |
2 |
p. A74- 1 p. |
artikel |
64 |
Design, Synthesis and Anti-HIV-1 Evaluation of Novel Arylazolylthioacetanilides as Potent NNRTIS
|
Liu, Xinyong |
|
2009 |
82 |
2 |
p. A44-A45 nvt p. |
artikel |
65 |
Design, Synthesis, and Biological Evaluation of Novel Fluoro Derivatives of BCNA
|
Derudas, Marco |
|
2009 |
82 |
2 |
p. A57- 1 p. |
artikel |
66 |
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors
|
Chimirri, Alba |
|
2009 |
82 |
2 |
p. A56-A57 nvt p. |
artikel |
67 |
Development of a Long Lasting Combination Microbicide Product Consisting of Highly Potent Compounds Exhibiting Multiple Mechanisms of Action
|
Watson, Karen |
|
2009 |
82 |
2 |
p. A67- 1 p. |
artikel |
68 |
Development of Hexadecyloxypropyl Tenofovir (CMX157) for HIV: Potential for Use as a Microbicide and Therapeutic
|
Lanier, Randall |
|
2009 |
82 |
2 |
p. A43- 1 p. |
artikel |
69 |
Development of Microbicides with Broad Based Anti-Infective Action
|
Herold, Betsy |
|
2009 |
82 |
2 |
p. A73- 1 p. |
artikel |
70 |
Discovery and In vitro Characterization of a Novel, Chain-terminating Tricyclic Nucleoside, GL60630, with Potent Anti-HCV Activity
|
Roberts, Christopher |
|
2009 |
82 |
2 |
p. A20- 1 p. |
artikel |
71 |
Discovery of New Inhibitors of the Influenza H5N1 Virus
|
Severson, William |
|
2009 |
82 |
2 |
p. A36-A37 nvt p. |
artikel |
72 |
4,4-Disubstituted Cyclohexylamine based CCR5 Chemokine Receptor Antagonists as Anti-HIV-1 agents
|
Duan, Maosheng |
|
2009 |
82 |
2 |
p. A57- 1 p. |
artikel |
73 |
Drug Resistance Mutations in HSV-1 UL5 Selected using a Helicase–Primase Inhibitor: Frequency and Effects on Virus Growth and Pathogenicity
|
Biswas, Subhajit |
|
2009 |
82 |
2 |
p. A68-A69 nvt p. |
artikel |
74 |
dUY11, A Rigid Amphipathic Fusion Inhibitor, Inhibits HCV Infectivity by Modulating Membrane Curvature
|
St. Vincent, M. |
|
2009 |
82 |
2 |
p. A21- 1 p. |
artikel |
75 |
EBNA1—A virally encoded protein binds cellular host promoters in a unique sequence and directly interferes with cellular gene expression. Implications for genomics approaches in drug design
|
Canaan, Allon |
|
2009 |
82 |
2 |
p. A69-A70 nvt p. |
artikel |
76 |
Editorial Board
|
|
|
2009 |
82 |
2 |
p. ii- 1 p. |
artikel |
77 |
Effects of Anti-human Papillomavirus (HPV) Disease Agents on HPV Episome Levels In Vitro: Cidofovir, Podophyllotoxin, and Pyrrole–Imidazole Polyamides
|
Edwards, Terri |
|
2009 |
82 |
2 |
p. A68- 1 p. |
artikel |
78 |
Effects of Antivirals via Intratympanic Delivery in GPCMV-related Hearing Loss
|
Ward, Jonette |
|
2009 |
82 |
2 |
p. A53- 1 p. |
artikel |
79 |
Escaping Development of Drug-Resistant Mutants: Basis for Effective Chemotherapy of Enterovirus Infections
|
Galabov, Angel S. |
|
2009 |
82 |
2 |
p. A38- 1 p. |
artikel |
80 |
Escaping Development of Drug-Resistant Mutants: Basis for Effective Chemotherapy of Enterovirus Infections
|
Galabov, Angel S. |
|
2009 |
82 |
2 |
p. A38-A39 nvt p. |
artikel |
81 |
Evaluation of Octadecyloxyethyl Esters of 3-Hydroxy-2-(phosphonomethoxy)propyl Nucleosides Against HCMV, HSV and Poxviruses
|
Valiaeva, Nadejda |
|
2009 |
82 |
2 |
p. A52- 1 p. |
artikel |
82 |
Evaluation of the Anti-HIV Activity of Natalizumab—An Antibody Against Integrin alpha4
|
Ballana, Ester |
|
2009 |
82 |
2 |
p. A23- 1 p. |
artikel |
83 |
Expression of Infectious Bursal Disease Virus (IBDV) Polyprotein and VP4 Protease
|
Vukea, Phillia |
|
2009 |
82 |
2 |
p. A55- 1 p. |
artikel |
84 |
Feglymycin, a Unique 13 Amino-acid Peptide, With a Novel Mechanism of Anti-HIV-1 Activity
|
Schols, Dominique |
|
2009 |
82 |
2 |
p. A25- 1 p. |
artikel |
85 |
FGI-104: A Broad-Spectrum Small Molecule Inhibitor of Viral Infection
|
Kinch, Michael |
|
2009 |
82 |
2 |
p. A39-A40 nvt p. |
artikel |
86 |
Formulation of Compounds for Vaginal and Rectal Delivery
|
Kiser, Patrick |
|
2009 |
82 |
2 |
p. A73- 1 p. |
artikel |
87 |
From β-Amino-γ-Sultone to New Bicyclic Pyridine and Pyrazine Heterocyclic Systems: Discovery of a Novel Class of HIV-1 Non-nucleoside Inhibitors
|
Velazquez, Sonsoles |
|
2009 |
82 |
2 |
p. A26-A27 nvt p. |
artikel |
88 |
Full Author Index – Abstract Number (Bold number signifies first author)
|
|
|
2009 |
82 |
2 |
p. A76-A81 nvt p. |
artikel |
89 |
Future Conferences
|
|
|
2009 |
82 |
2 |
p. A83- 1 p. |
artikel |
90 |
HCV and the Immune Response
|
Lemon, Stan |
|
2009 |
82 |
2 |
p. A19- 1 p. |
artikel |
91 |
Hepatitis C Virus NS5A Protein In Vitro Modulates Template Selection by the RNA-dependent RNA Polymerase
|
Ivanova, Olga |
|
2009 |
82 |
2 |
p. A28-A29 nvt p. |
artikel |
92 |
Highly Potent and Dual-acting Pyrimidinedione Inhibitors of HIV-1 Possess a High Genetic Barrier to Resistance
|
Buckheit, Robert |
|
2009 |
82 |
2 |
p. A44- 1 p. |
artikel |
93 |
High-throughput In Vitro HIV Rev-multimerization Assay
|
Vercruysse, Thomas |
|
2009 |
82 |
2 |
p. A46- 1 p. |
artikel |
94 |
High Throughput Screening of Protease Inhibitor Libraries Using a Novel Dual Pseudotype-Based Assay for SARS-CoV Entry
|
Zhou, Yanchen |
|
2009 |
82 |
2 |
p. A37-A38 nvt p. |
artikel |
95 |
HiT QSAR Study of Antivirals’ Bioavailability
|
Artemenko, Anatoly |
|
2009 |
82 |
2 |
p. A56- 1 p. |
artikel |
96 |
HIV-1 Gag Matrix Protein Fragments and Polyacid Conjugates Designed for the HIV Inhibition
|
Karaseva, E. |
|
2009 |
82 |
2 |
p. A59- 1 p. |
artikel |
97 |
Human Immunodeficiency Virus Type 1 Does Not Escape From Novel Single-Stranded DNAzyme Expression-Mediated Inhibition
|
Habu, Yuichiro |
|
2009 |
82 |
2 |
p. A24- 1 p. |
artikel |
98 |
Identification and Characterization of Pyrimidinediones as Potent Non-nucleoside Reverse Transcriptase Inhibitors of Hepatitis B virus
|
Yang, Lu |
|
2009 |
82 |
2 |
p. A32- 1 p. |
artikel |
99 |
Identification and Mechanistic Studies on a Novel Class of Influenza Virus Fusion Inhibitors
|
Vanderlinden, Evelien |
|
2009 |
82 |
2 |
p. A70- 1 p. |
artikel |
100 |
Identification of a Small-molecule Antiviral with Broad-spectrum Application to Multiple, Lethal Virus Types
|
Yunus, Abdul |
|
2009 |
82 |
2 |
p. A74-A75 nvt p. |
artikel |
101 |
Identification of the Type of Cells Responsible for Transfer of Herpes Simplex Virus (HSV) and Vaccinia Virus (VACV) Infection to Epithelial Cells Grown in 3D
|
Andrei, Graciela |
|
2009 |
82 |
2 |
p. A68- 1 p. |
artikel |
102 |
Immediate and Persistent Anti-HIV-1 Activity of the Biguanide-based Compound NB325 Involves Specific Interactions with the Viral Co-receptor CXCR4
|
Thakkar, Nina |
|
2009 |
82 |
2 |
p. A26- 1 p. |
artikel |
103 |
Indole Derivatives Are Potent Inhibitors of HIV Integrase
|
Selvam, Periyasamy |
|
2009 |
82 |
2 |
p. A42- 1 p. |
artikel |
104 |
Induction of HIV-1 Gene Expression in Human Monocytic Cells by the Failed Microbicide Carrageenan Occurs Through Activation of Toll-like Receptor 4 (TLR4)
|
Keogan, Shawn |
|
2009 |
82 |
2 |
p. A64- 1 p. |
artikel |
105 |
Induction of Interferon Gamma Inducible Protein 10 by SARS-CoV Infection, Interferon Alfacon 1 and Interferon Inducer in Human Bronchial Epithelial Calu-3 Cells and BALB/c Mice
|
Kumaki, Yohichi |
|
2009 |
82 |
2 |
p. A34- 1 p. |
artikel |
106 |
Induction of Lytic Cytotoxicity by NF-(B Inhibitors in Epstein-Barr Virus-associated Gastric Carcinoma Cells
|
Suarez, Paula Ordonez |
|
2009 |
82 |
2 |
p. A50- 1 p. |
artikel |
107 |
Inhibition of Hepatitis B Virus Replication by a Set of Small Interferon-stimulated Genes
|
Guo, Haitao |
|
2009 |
82 |
2 |
p. A22- 1 p. |
artikel |
108 |
Inhibition of Herpes Simplex Virus by Polyamines
|
Yudovin-Farber, Ira |
|
2009 |
82 |
2 |
p. A53- 1 p. |
artikel |
109 |
Inhibition of Herpesvirus Replication With 5-Iodo-4′-Thio-2′-Deoxyuridine
|
Prichard, Mark |
|
2009 |
82 |
2 |
p. A67- 1 p. |
artikel |
110 |
Inhibition of Influenza Virus Replication: Discovery and Development of Therapeutic Compounds which Suppress Viral RNA Synthesis
|
Hartman, Tracy |
|
2009 |
82 |
2 |
p. A33- 1 p. |
artikel |
111 |
In Silico Screening for Anti-HIV-1 Compounds Targeting to Human Cyclin T1
|
Hamasaki, Takayuki |
|
2009 |
82 |
2 |
p. A24- 1 p. |
artikel |
112 |
Interactions Between the Human Oligopeptide Transporter, hPepT1 and Serine Side-chain-linked Cidofovir Prodrugs
|
Sala-Rabanal, Monica |
|
2009 |
82 |
2 |
p. A53-A54 nvt p. |
artikel |
113 |
Invitation to the Twenty-Third International Conference on Antiviral Research, San Francisco, USA, 25–28th April, 2010
|
|
|
2009 |
82 |
2 |
p. A82- 1 p. |
artikel |
114 |
In Vitro Activity and In Vivo Pharmacokinetics of Highly Potent Phosphoramidate Nucleoside Analogue Inhibitors of Hepatitis C NS5B
|
Hutchins, J. |
|
2009 |
82 |
2 |
p. A28- 1 p. |
artikel |
115 |
In vitro Anti-hepatitis C Virus (HCV) Activities and Resistance Profile of Debio 025, A Non-immunosuppressive Cyclophilin Binding Molecule
|
Coelmont, Lotte |
|
2009 |
82 |
2 |
p. A20- 1 p. |
artikel |
116 |
In Vitro Anti-Influenza Virus Effect of a Protease Inhibitor from a Streptomyces Strain
|
Serkedjieva, Julia |
|
2009 |
82 |
2 |
p. A36- 1 p. |
artikel |
117 |
In vitro transport, activation and antiviral evaluation of new HPMPA prodrugs synthesized on a solid support
|
Krylov, Ivan S. |
|
2009 |
82 |
2 |
p. A75- 1 p. |
artikel |
118 |
In Vivo Efficacy Evaluation of Vaccines Against H5N1 Influenza Virus
|
Mytle, Nutan |
|
2009 |
82 |
2 |
p. A71- 1 p. |
artikel |
119 |
l-Analogs of 1-Beta-d-Ribofuranosyl-2-Bromo-5,6-Dichlorobenzimidazole (BDCRB) Inhibit Human Herpesvirus-6 Replication
|
Prichard, Mark |
|
2009 |
82 |
2 |
p. A51- 1 p. |
artikel |
120 |
Macrocyclic Polyamines Targeting the Cellular HIV Co-receptors, CXCR4 and CCR5
|
Hamal, Sunil |
|
2009 |
82 |
2 |
p. A58- 1 p. |
artikel |
121 |
Microbicide Product Development: What Is A Microbicide?
|
Turpin, Jim |
|
2009 |
82 |
2 |
p. A73- 1 p. |
artikel |
122 |
Motor Unit Number Estimation as a Therapeutic Marker in Acute and Persistent West Nile Virus Infection in Hamsters
|
Morrey, John D. |
|
2009 |
82 |
2 |
p. A72- 1 p. |
artikel |
123 |
Multivalent Synthetic Lectin Polymers Against HIV
|
Jay, Julie |
|
2009 |
82 |
2 |
p. A63-A64 nvt p. |
artikel |
124 |
Murine Model of Recurrent Vaginal HSV-2 Shedding and Effect of Acyclovir
|
Cardin, Rhonda |
|
2009 |
82 |
2 |
p. A69- 1 p. |
artikel |
125 |
Mutation of the Thymidine Kinases Encoded by Herpes Simplex Virus or Vaccinia Virus can Confer Resistance to 5-Iodo-4′-thio-2′-deoxyuridine
|
Harden, Emma |
|
2009 |
82 |
2 |
p. A48- 1 p. |
artikel |
126 |
New Methods to Identify and Analyze HCV Helicase Inhibitors
|
Frick, David |
|
2009 |
82 |
2 |
p. A19- 1 p. |
artikel |
127 |
New peptidomimetic prodrugs of acyclic and cyclic cidofovir: sar studies of chemical and enzymatic activation mechanisms
|
McKenna, Charles E. |
|
2009 |
82 |
2 |
p. A75- 1 p. |
artikel |
128 |
New Targets within Hepatitis C Virus NS4B
|
Glenn, Jeffrey |
|
2009 |
82 |
2 |
p. A19- 1 p. |
artikel |
129 |
Nonoxynol-9 (N-9), After Repeated Applications, Does not Result in Cumulative Damage to the Murine Cervicovaginal Epithelium
|
Lozenski, Karissa |
|
2009 |
82 |
2 |
p. A64-A65 nvt p. |
artikel |
130 |
Notes to Authors
|
|
|
2009 |
82 |
2 |
p. CO3- 1 p. |
artikel |
131 |
Novel 9-Arylpurines, as Selective Inhibitors of In Vitro Enterovirus Replication
|
Thibaut, Hendrik Jan |
|
2009 |
82 |
2 |
p. A73- 1 p. |
artikel |
132 |
Novel Broad-Spectrum Biopharmaceuticals: From HIV-1 to Pandemic Influenza A Virus
|
Jean, François |
|
2009 |
82 |
2 |
p. A70-A71 nvt p. |
artikel |
133 |
Novel HCV Replication Mouse Model Using Human Hepatocellular Carcinoma Xenografts
|
Guévin, Carl |
|
2009 |
82 |
2 |
p. A28- 1 p. |
artikel |
134 |
Novel Imino Sugar Derivatives Demonstrate Potent Antiviral Activity against Dengue Virus
|
Chang, Jinhong |
|
2009 |
82 |
2 |
p. A72-A73 nvt p. |
artikel |
135 |
Novel Small Molecule Inhibitors of Dengue Virus Replication
|
Byrd, Chelsea |
|
2009 |
82 |
2 |
p. A38- 1 p. |
artikel |
136 |
Nucleoside Phosphonate Analogues Modified by Lipophilic Cage Moiety as Potential Antiviral Agents
|
Klimochkin, Yuri |
|
2009 |
82 |
2 |
p. A60- 1 p. |
artikel |
137 |
Oseltamivir-resistant Subpopulations of H5N1 Influenza Variants are Genetically Stable and Virulent in Ferrets
|
Govorkova, Elena A. |
|
2009 |
82 |
2 |
p. A33- 1 p. |
artikel |
138 |
Phenotyping Human Cytomegalovirus Drug Resistance Mutations Using a Recombinant Virus Incorporating EGFP
|
Chevillotte, Meike |
|
2009 |
82 |
2 |
p. A47- 1 p. |
artikel |
139 |
Phosphoramidate Protides Greatly Enhance the Anti-HCV Activity of 2′-Methylguanosine
|
Madela, Karolina |
|
2009 |
82 |
2 |
p. A29-A30 nvt p. |
artikel |
140 |
Plenary: Filoviral Minigenome systems and iVLPs as tools for antiviral research
|
Becker, Stephan |
|
2009 |
82 |
2 |
p. A70- 1 p. |
artikel |
141 |
Pradimicin-S is a Highly Soluble Non-peptidic Small-size Carbohydrate-binding Antibiotic that may Qualify as a Potential Drug Lead for HIV Treatment
|
Balzarini, J. |
|
2009 |
82 |
2 |
p. A44- 1 p. |
artikel |
142 |
Pre-clinical Development of IQP-0410, a Highly Potent Dual-acting Agent for the Therapy of HIV-1 Infection
|
Kaludov, Nick |
|
2009 |
82 |
2 |
p. A46- 1 p. |
artikel |
143 |
Preclinical Pharmacokinetic, Toxicokinetic and Toxicology Results for Cyclopropavir, a Promising New Agent for the Treatment of Beta- and Gamma-herpesviruses
|
Bowlin, Terry |
|
2009 |
82 |
2 |
p. A46-A47 nvt p. |
artikel |
144 |
Predicted Models of Resistance and Hypersensitivity Conferred by Natural Polymorphisms of HIV-1 Integrase
|
Hewer, Raymond |
|
2009 |
82 |
2 |
p. A24- 1 p. |
artikel |
145 |
Predictive Factors to Response to Interferon Therapies for Treatment-naive Patients Infected with Hepatitis C Virus in Islamabad and Vicinity Areas: A Study from Pakistan
|
Raza, Abida |
|
2009 |
82 |
2 |
p. A31- 1 p. |
artikel |
146 |
Prophylactic Efficacy of Intranasally Administered HSP Nanoparticles for Treating a Lethal SARS-CoV Infection in BALB/c Mice
|
Barnard, Dale |
|
2009 |
82 |
2 |
p. A32- 1 p. |
artikel |
147 |
Protective Effect of a Fungal Superoxide Dismutase, Combined with a Plant Polyphenol Extract and Rimantadine Hydrochloride in the Murine Experimental Influenza Virus Infection
|
Serkedjieva, Julia |
|
2009 |
82 |
2 |
p. A36- 1 p. |
artikel |
148 |
Pyrazine Derivative Treatment of Phleboviral Infection in Cell Culture and Rodent Model Systems
|
Gowen, Brian |
|
2009 |
82 |
2 |
p. A39- 1 p. |
artikel |
149 |
Recruitment of the TSG101/ESCRT-I Machinery in Host Cells by Influenza Virus: Implications for Broad-Spectrum Therapy
|
Diaz, Leyla |
|
2009 |
82 |
2 |
p. A71- 1 p. |
artikel |
150 |
Resistance Developed Against Alamethicin an Antimicrobial Peptide in Enterococcus faecalis is Directly Proportional to its Concentration
|
Mehla, Jitender |
|
2009 |
82 |
2 |
p. A65- 1 p. |
artikel |
151 |
Rimantadine and Oseltamivir Combination Effects in a Therapeutic Course of Application Against Influenza A (H3N2) in Mice
|
Simeonova, Lora |
|
2009 |
82 |
2 |
p. A37- 1 p. |
artikel |
152 |
Role of NA mutations Conferring Resistance to NA Inhibitors on Viral Fitness and Pathogenicity in A/Turkey/15/06 (H5N1) Influenza Virus
|
Ilyushina, Natalia A. |
|
2009 |
82 |
2 |
p. A71- 1 p. |
artikel |
153 |
Selection and Characterization of (S)-1-[3-Hydroxy-2-(Phosphonomethoxypropyl)-2,6-Diaminopurine [HPMPDAP] Resistant Camelpox Viruses
|
Duraffour, Sophie |
|
2009 |
82 |
2 |
p. A67-A68 nvt p. |
artikel |
154 |
SEVI and Semen Impair the Anti-HIV-1 Activity of Drugs and Microbicides
|
Kyeong-Ae, Kim |
|
2009 |
82 |
2 |
p. A64- 1 p. |
artikel |
155 |
Silibinin (Legalon-SIL) Inhibits HCV Replication In Vitro
|
Najera, Isabel |
|
2009 |
82 |
2 |
p. A30- 1 p. |
artikel |
156 |
Small-molecule CCR5 Ligands that may Spare the CCR5 Function: Opportunity for New Antiviral Discovery?
|
Kazmierski, Wieslaw |
|
2009 |
82 |
2 |
p. A43- 1 p. |
artikel |
157 |
Structural Basis of the Disoxaril Resistance and Dependence of Coxsackievirus B1
|
Nikolova, Ivanka |
|
2009 |
82 |
2 |
p. A41- 1 p. |
artikel |
158 |
Structure–Activity Relationship of a Novel Class of Aglycoristocetin Derivatives with Potent and Broad Activity Against Influenza Viruses
|
Naesens, Lieve |
|
2009 |
82 |
2 |
p. A34-A35 nvt p. |
artikel |
159 |
Study of Anti-Epstein–Barr Virus Activity of Novel Fluorinated Heterocyclic Nucleoside Analogues
|
Nesterova, N. |
|
2009 |
82 |
2 |
p. A50- 1 p. |
artikel |
160 |
Study of Anti-Epstein–Barr virus activity of novel fluorinated heterocyclic nucleoside analogues
|
Nesterova, N. |
|
2009 |
82 |
2 |
p. A49- 1 p. |
artikel |
161 |
Study of the Retention of Metabolites of 4′-ED4T, A Novel Anti-HIV-1 Thymidine Analog, in Cells
|
Wang, Xin |
|
2009 |
82 |
2 |
p. A27- 1 p. |
artikel |
162 |
Synergistic Inhibition of Bovine Leukemia Virus Replication In Vitro by Ribavirin and alpha-Interferon
|
Isaacson, Jeffrey |
|
2009 |
82 |
2 |
p. A24-A25 nvt p. |
artikel |
163 |
Synthesis and Antiviral Activity of Substituted Uracils
|
Ivanov, Alexander |
|
2009 |
82 |
2 |
p. A58- 1 p. |
artikel |
164 |
Synthesis and Biological Evaluation of Acyclic Nucleotide Analogues of Bicyclic Pyrimidine Bases
|
Janeba, Zlatko |
|
2009 |
82 |
2 |
p. A58-A59 nvt p. |
artikel |
165 |
Synthesis and Biological Studies of Mutagenic Ribonucleoside Analogues as Potential Inducers of Error Catastrophe of Riboviruses
|
Camarasa, María-José |
|
2009 |
82 |
2 |
p. A54- 1 p. |
artikel |
166 |
Synthesis and Evaluation of Novel Acyclovir Phosphoramidates as Anti-HIV Agents
|
Carta, Davide |
|
2009 |
82 |
2 |
p. A56- 1 p. |
artikel |
167 |
Synthesis and Properties of CycloSal-phosphatetriesters of Fluorescent Bicyclic Nucleoside Analogues (BCNAS)
|
Pertenbreiter, Florian |
|
2009 |
82 |
2 |
p. A62- 1 p. |
artikel |
168 |
Synthesis and SAR of 9-Arylpurines as Novel Inhibitors of Enterovirus Replication
|
Aguado, Leire |
|
2009 |
82 |
2 |
p. A55- 1 p. |
artikel |
169 |
Synthesis, Antiviral Activity, and Cytotoxicity of Some Novel 2-Phenyl-3-disubstituted Quinazolin-4(3H)-ones
|
Selvam, Periyasamy |
|
2009 |
82 |
2 |
p. A55- 1 p. |
artikel |
170 |
Synthesis of CADA Analog Prodrugs Designed as Novel Down-modulators of the CD4 Receptor
|
Scarbrough, Emily |
|
2009 |
82 |
2 |
p. A63- 1 p. |
artikel |
171 |
Targeting Hepatitis C Virus NS2—An Unusual Protease with Multiple Functions
|
Pietschmann, Thomas |
|
2009 |
82 |
2 |
p. A19- 1 p. |
artikel |
172 |
The Activity of New Cage Compounds Against Avian Influenza Virus (H5N1)
|
Belanov, Evgeny |
|
2009 |
82 |
2 |
p. A32-A33 nvt p. |
artikel |
173 |
The Application of Phosphoramidate Protide Technology to Acyclovir confers Novel Anti-HIV Inhibition
|
Derudas, Marco |
|
2009 |
82 |
2 |
p. A57- 1 p. |
artikel |
174 |
The Complexities of Hepatitis C Virus Entry
|
McKeating, Jane |
|
2009 |
82 |
2 |
p. A19- 1 p. |
artikel |
175 |
The Development of HIV-1 NCP7 Inhibitors as Components in Combination Topical Microbicides
|
Watson, Karen |
|
2009 |
82 |
2 |
p. A66-A67 nvt p. |
artikel |
176 |
The Effect of Human Cytomegalovirus Proteins PUL97 and PUL27 on Host Interferon Responses
|
Gill, Rachel |
|
2009 |
82 |
2 |
p. A47- 1 p. |
artikel |
177 |
The Hepatitis C Virus NS5A: New Functions and New Mysteries
|
Tellinghuisen, Tim |
|
2009 |
82 |
2 |
p. A19- 1 p. |
artikel |
178 |
The Microbicide Pipeline: Clinical Development Success and Failure
|
Romano, Joseph |
|
2009 |
82 |
2 |
p. A74- 1 p. |
artikel |
179 |
Therapeutic Efficacy of the Amphipathic DNA Polymer REP 9AC in the Treatment of Duck Hepatitis B Virus Infection In Vivo
|
Nordeen, Faseeha |
|
2009 |
82 |
2 |
p. A30-A31 nvt p. |
artikel |
180 |
The transport of anti-HIV drugs across blood–CNS interfaces: Summary of current knowledge and recommendations for further research
|
Varatharajan, Lavanya |
|
2009 |
82 |
2 |
p. A99-A109 nvt p. |
artikel |
181 |
The Twenty-Second International Conference on Antiviral Research
|
|
|
2009 |
82 |
2 |
p. A1-A18 nvt p. |
artikel |
182 |
Toward Unsymmetrical CADA Analogs as Novel Down-modulators of the CD4 Receptor
|
Demillo, Violeta |
|
2009 |
82 |
2 |
p. A43-A44 nvt p. |
artikel |
183 |
Use of the BelloCell System to Determine the Optimal Dose of Ribavirin to Inhibit the Expression of an HCV Replicon in 2209-23 Cells
|
McSharry, James |
|
2009 |
82 |
2 |
p. A30- 1 p. |
artikel |
184 |
Using the C57BL/6 and SKH1 Strains to Evaluate the Efficacy of CMX001 Following Lethal Respiratory Infections with Ectromelia Virus
|
Parker, Scott |
|
2009 |
82 |
2 |
p. A73- 1 p. |
artikel |
185 |
Using the Conrad Testing Algorithm to Evaluate the Cytotoxicity and Anti-HIV-1 Activity of Candidate Microbicide Compounds
|
Passic, Shendra |
|
2009 |
82 |
2 |
p. A65- 1 p. |
artikel |
186 |
Virtual Reality Applications in Antiviral Drug Design
|
Zonta, Nicola |
|
2009 |
82 |
2 |
p. A74- 1 p. |
artikel |
187 |
West Nile Virus Helicase: Homology Modeling and Docking Studies
|
Khedr, Mohammed |
|
2009 |
82 |
2 |
p. A60- 1 p. |
artikel |
188 |
ZNRD1 as a Host Cellular Factor Influencing HIV-1 Replication
|
Ballana, Ester |
|
2009 |
82 |
2 |
p. A45- 1 p. |
artikel |